Clinical Trial Update: Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

View source ↗

Summary

A prospective validation study exploring whether CD8+ TEMRA cells can predict healing outcomes after fracture, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Union of Fracture
• Fracture
• Nonunion of Fracture

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Fracture Non Union, Fracture Healing | Status: RECRUITING